title: Reversible dopamine transporter reduction in drug-induced Parkinsonism.
authors: Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy.
authors: Roberto
authors: R
authors: Cilia
authors: Giorgio
authors: G
authors: Marotta
authors: Alice
authors: A
authors: Belletti
authors: Chiara
authors: C
authors: Siri
authors: Gianni
authors: G
authors: Pezzoli
mesh_terms: D000368:Aged; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000188:drug therapy; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000378:metabolism*; D010879:Piperazines / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D011877:Radionuclide Imaging
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D010879:Piperazines; D015363:Quinolones; D016651:Lithium Carbonate; D000068180:Aripiprazole